Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

GPs are free to prescribe semaglutide to all eligible patients in line with NICE guidelines after long-term shortages have ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Bacterial vaginosis affects nearly a third of women worldwide and can cause infertility, premature births and newborn deaths.

GLP-1 drugs include semaglutide, liraglutide and dulaglutide, now marketed as Ozempic, Wegovy, Saxenda, Victoza and Trulicity ...

Advt Eli Lilly's Trulicity (dulaglutide) was the most commonly used GLP-1 drug in the study. Some patients received Novo Nordisk's Ozempic (semaglutide) or the company's older Victoza (liraglutide).

The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP-1 class rival, further bolsters semaglutide's profile ahead of its anticipated approval later this year as ...

In recent years, there have been more developments in the area of diabetes management, with the emergence of metformin and more recently semaglutide and dulaglutide. However, despite these ...